McDermott advised Dynacure on its merger. Dynacure, a company that aims to develop and commercialize new therapies to improve the lives of patients with rare diseases...
You must be a Standard 1 Year member to access this content.
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
You must be a Standard 1 Year member to access this content.
Dentons Paris advised ImCheck Therapeutics on the transaction. McDermott Will & Emery advised McDermott advised EarlyBird and Andera Partners. Goodwin advised Bpifrance. Bpifrance, through its InnoBio...
You must be a Standard 1 Year member to access this content.
Gide advised Goldman Sachs and SVB Leerink LLC. McDermott Will & Emery advised DBV Technologies. DBV Technologies, a clinical-stage biopharmaceutical company, announced a private placement financing...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Diabeloop on the deal. Chammas & Marcheteau advised LBO France. Diabeloop, a Grenoble-based artificial intelligence company specialising in the treatment of...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure...
You must be a Standard 1 Year member to access this content.
